Supplementary Figure S2 from A tumor suppressive-molecular axis EP300/circRERE/miR-6837-3p/MAVS activates type I interferon pathway and anti-tumor immunity to suppress colorectal cancer | Synapse
September 16, 2024
Supplementary Figure S2 from A tumor suppressive-molecular axis EP300/circRERE/miR-6837-3p/MAVS activates type I interferon pathway and anti-tumor immunity to suppress colorectal cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Figure S2: Characteristics of circRERE in CRC cells.